Head-to-head · Cost-Efficiency Index
CoreAge Rx vs Mochi Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxMochi Health
Shoppers who want obesity-medicine physician access bundled with the prescription, and don't mind two separate line items.
Visit Mochi HealthThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 56. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. Mochi Health still earns a C — Shoppers who want obesity-medicine physician access bundled with the prescription, and don't mind two separate line items.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | Mochi Health |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 56/100 |
| Semaglutide / mo | $99/mo | $178/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide / mo | $149/mo | $278/mo (starting dose, plus a separate fee, compounded) |
| Semaglutide / yr (modeled) | $1,188 | $2,136 |
| Tirzepatide / yr (modeled) | $1,788 | $3,336 |
| Coverage | All 50 states | 15 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #1 | #330 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
Mochi Health
56/100Where the value is
- Names five board-certified obesity-medicine physicians on its About page (Valledor, Jones, Barrick, A. Patel, Am. Patel MDs/DOs), unusual specificity for this tier of provider
- Available in all 50 states per the About page, a real expansion from the network dataset's outdated '15 states'
- Membership includes ongoing care-team messaging and coaching, not just a one-time prescription
The tradeoffs
- The advertised '$99' and '$199' medication prices are NOT the monthly cost — a separate $79/mo membership is mandatory and stacks on top, so the real floor is $178/mo (semaglutide) and $278/mo (tirzepatide)
- No compounding pharmacy is named anywhere on the site, including a dedicated /pharmacy page that markets the partnership program without ever identifying a partner
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.